Literature DB >> 15767476

Changing trends in the microbiologic aspects of postcataract endophthalmitis.

Franco M Recchia1, Brandon G Busbee, Robert B Pearlman, Cynthia A Carvalho-Recchia, Allen C Ho.   

Abstract

OBJECTIVE: To analyze the microbiologic spectrum and in vitro susceptibility profiles over the last 11 years of organisms isolated from the vitreous of patients with endophthalmitis following cataract surgery.
METHODS: Records of 497 consecutive patients treated at 1 institution for clinically suspected endophthalmitis following cataract surgery from July 1989 through June 2000 were reviewed. Results of microbiologic culture and in vitro antibiotic susceptibility testing from the periods 1989 to 1994 and 1995 to 2000 were compared.
RESULTS: Between the 2 periods, there was a significant increase in the incidence of gram-positive bacteria (92%-97% of bacterial isolates). There was a significant increase in resistance among all bacterial isolates to ciprofloxacin (23%-37%; P = .02). There was increased resistance among coagulase-negative staphylococci to both ciprofloxacin (20%-38%) and cefazolin (19%-40%). Resistance to bacitracin, trimethoprim-sulfamethoxazole, and vancomycin remained unchanged. Vancomycin retained in vitro efficacy against more than 99% of gram-positive bacteria. Ceftazidime was effective against 100% of gram-negative bacteria tested.
CONCLUSIONS: The spectrum of pathogens causing postcataract endophthalmitis is changing, and resistance to antibiotics used for its prophylaxis has grown. These findings may affect the empirical treatment of postcataract endophthalmitis, as well as the use and choice of antibiotics in patients undergoing cataract surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767476     DOI: 10.1001/archopht.123.3.341

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  38 in total

1.  A class I (Senofilcon A) soft contact lens prevents UVB-induced ocular effects, including cataract, in the rabbit in vivo.

Authors:  Frank J Giblin; Li-Ren Lin; Victor R Leverenz; Loan Dang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

3.  Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK.

Authors:  A Gupta; H O Orlans; S J Hornby; I C J W Bowler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-11       Impact factor: 3.117

4.  The additional value of blood culture bottles in the diagnosis of endophthalmitis.

Authors:  H S Tan; E A E Ghyczy-Carlborg; L Spanjaard; M D de Smet
Journal:  Eye (Lond)       Date:  2011-06-17       Impact factor: 3.775

5.  Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.

Authors:  Jesse DeLeon; Bruce E Silverstein; Catherine Allaire; Lynne S Gearinger; Kirk M Bateman; Timothy W Morris; Timothy L Comstock
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

6.  Risk factors for aerobic bacterial conjunctival flora in preoperative cataract patients.

Authors:  S Hoshi; M Hashida; K Urabe
Journal:  Eye (Lond)       Date:  2016-07-15       Impact factor: 3.775

7.  Toward improving therapeutic regimens for Bacillus endophthalmitis.

Authors:  Brandt J Wiskur; Michael L Robinson; Allison J Farrand; Billy D Novosad; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

8.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

9.  MRSA and cataract surgery - reflections for practice.

Authors:  L F Porter; R U Khan; A Hannan; S P Kelly
Journal:  Clin Ophthalmol       Date:  2010-10-21

10.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.